Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective observational study of dupilumab in Japanese patients with COPD
jRCT1020250021Recruiting
- Sponsor
- Sanofi
- Start
- Nov 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of dupilumab in chronic obstructive pulmonary disease (COPD), sponsored by Sanofi. Started Nov 2025; status: recruiting.
02
Drugs
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT1020250021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1020250021.